Alembic Pharma gets final USFDA nod for hypertension drug

"Alembic Pharmaceuticals Ltd (Alembic) today announced it has received final approval from the US Food Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bosentan tablets, 62.5 mg and 125 mg," the firm said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2RkhKYN